demeclocycline
Selected indexed studies
- Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review. (Int J Clin Pract, 2015) [PMID:26289137]
- Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes. (Front Immunol, 2020) [PMID:32153581]
- Demeclocycline-induced diabetes insipidus. (JAMA, 1974) [PMID:4277429]
_Worker-drafted node — pending editorial review._
Connections
demeclocycline is a side effect of
Sources
- Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review. (2015) pubmed
- Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes. (2020) pubmed
- Demeclocycline-induced diabetes insipidus. (1974) pubmed
- Renal effects of demeclocycline. (1980) pubmed
- Demeclocycline-induced renal failure. (1977) pubmed
- The tetracyclines. (1970) pubmed
- Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla. (2013) pubmed
- Demeclocycline-induced nephrogenic diabetes insipidus. In-vivo and in-vitro studies. (1973) pubmed
- Demeclocycline. Treatment for syndrome of inappropriate antidiuretic hormone secretion. (1977) pubmed
- Ledermix in children. (2021) pubmed